37S.F Spineway SA
- Market cap
- EUR 3.16M
- P/E
- -
- P/B
- 0.14x
- ROE
- -9.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 37S.F undervalued?
Graham numberThe Graham number of Spineway SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Spineway SA fundamental analysis
No fundamental analysis for Spineway SA yet.
Spineway SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Spineway SA
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Full company profileSpineway SA financial statements
Spineway SA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 4.29M | 7.43M | 10.5M | 12.0M | 12.4M |
| Gross Profit | 3.46M | 5.99M | 7.88M | 8.45M | 9.01M |
| Operating Income | -1.41M | -3.19M | -4.27M | -884K | -1.61M |
| EBITDA | - | -2.12M | -4.64M | -1.63M | -727K |
| Net Income | -1.58M | -3.14M | -6.51M | -3.87M | -2.24M |
| EPS | -8,082 | -1,723 | -91 | -0.13 | -0.06 |
| Balance Sheet | |||||
| Total Assets | 25.6M | 27.7M | 26.3M | 30.4M | 29.5M |
| Total Liabilities | 4.69M | 5.69M | 7.26M | 6.17M | 6.40M |
| Shareholders' Equity | 20.9M | 22.0M | 19.1M | 24.2M | 23.1M |
| Cash & Short-term Investments | 13.9M | 5.53M | 1.80M | 4.52M | 3.50M |
| Cash Flow | |||||
| Operating Cash Flow | -1.80M | -1.62M | -5.83M | -3.27M | -163K |
| Capital Expenditure | 490K | 0.00 | 1.46M | 0.00 | 0.00 |
| Free Cash Flow | -1.80M | -1.62M | -7.29M | -3.27M | -163K |
| Ratios | |||||
| ROE | -7.6% | -14.3% | -34.2% | -15.9% | -9.7% |
| ROA | -6.2% | -11.3% | -24.7% | -12.7% | -7.6% |
| Net Profit Margin | -36.9% | -42.2% | -61.9% | -32.3% | -18.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Spineway SA dividends
Spineway SA has not paid dividends in the last 6 fiscal years.
Last stock split: 1:2000 on Feb 27, 2024.
Who owns Spineway SA
Ownership data of Spineway SA is not available yet.
Spineway SA company profile
- Company name
- Spineway SA
- Ticker
- 37S.F
- ISIN
- FR001400N2P2
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Employees
- 43
- Fiscal year end
- December
- Address
- 7, allEe Moulin Berger, Ecully, France, 69130
- Phone
- 33 4 72 77 01 52
- Website
- spineway.com
About Spineway SA
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Spineway SA management
8- Mr. Stephane Le RouxChairman, CEO & President
- Mr. David SiegristFinancial Director
- Ms. Agnès MignaniHuman Resources Manager
- Ms. Sandrine CarleDeputy Chief Executive Officer · born 1971
- Mr. Guillaume BertetController
- Mr. Mickaël BattistiController
- Ms. Marie-Christelle DesmollesController
- Mr. Jon R. LuedkeCEO of Spineway Inc. · born 1965